AIDA (all-trans retinoic acid + idarubicin) in newly diagnosed acute promyelocytic leukemia: A Gruppo Italiano Malattie Ematologiche Maligne dell'Adulto (GIMEMA) pilot study

Blood

Volumn 88, Issue 4, 1996, Pages 1390-1398

  Avvisati, Giuseppe ^b   Lo Coco, Francesco ^b   Diverio, Daniela ^b   Falda, Michele ^b   Ferrara, Felicetto ^b   Lazzarino, Mario ^b   Russo, Domenico ^b   Petti, Maria Concetta ^b   Mandelli, Franco ^a  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

CYTARABINE; DEXAMETHASONE; ETOPOSIDE; IDARUBICIN; MITOXANTRONE; RETINOIC ACID; RETINOIC ACID RECEPTOR; TIOGUANINE;

ACUTE MYELOBLASTIC LEUKEMIA; ADOLESCENT; ADULT; AGED; ARTICLE; CANCER MORTALITY; CANCER RECURRENCE; CANCER REGRESSION; CHILD; CLINICAL ARTICLE; CLINICAL PROTOCOL; CLINICAL TRIAL; FEMALE; HEMOPTYSIS; HUMAN; HYBRID GENE; INTRAMUSCULAR DRUG ADMINISTRATION; INTRAVENOUS DRUG ADMINISTRATION; MALE; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RETINOIC ACID SYNDROME; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SUBCUTANEOUS DRUG ADMINISTRATION; TREATMENT OUTCOME;

EID: 0029819203     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v88.4.1390.bloodjournal8841390     Document Type: Article

References (50)

1. Avvisati G, ten Cate JW, Mandelli F: Acute promyelocytic leukaemia. Br J Haematol 81:315, 1992
2. Warrell RP, de Thé H, Wang Z-Y, Degos L: Acute promyelocytic leukemia N Engl J Med 329:177, 1993
3. Grignani F, Fagioli M, Alcalay M, Longo L, Pandolfi PP, Donti E, Biondi A, Lo Coco F, Grignani F, Pelicci PG: Acute promyelocytic leukemia: From genetics to treatment. Blood 83:10, 1994
4. Rowley JD, Golomb HM, Dougherty C: (15; 17) Translocation, a consistent chromosomal change in acute promyelocytic leukaemia. Lancet 1:549, 1977
5. Avvisati G, ten Cate JW, Mandelli F: The coagulopathy in acute promyelocytic leukemia: DIC?, in Muszbek L (ed): Hemostasis and Cancer. Boca Raton, FL, CRC, 1987, p 91
6. Tallman M, Kwaan HC: Reassessing the hemostatic disorder associated with acute promyelocytic leukemia. Blood 79:543, 1992
7. Kakizuka A. Miller WH Jr, Umesono K, Warrel RP Jr, Frankel SR, Murty VVVS, Dmitrovsky E, Evans RM: Chromosomal translocation t(15;17) in human acute promyelocytic leukaemia fuses RARα with a novel putative transcription factor. PML. Cell 66:663, 1991
8. de Thé H, Lavau C, Marchio A, Chomienne C, Degos L, Dejean A: The PML-RARα fusion m-RNA generated by the t(15; 17) translocation in acute promyelocytic leukaemia encodes a functionally altered RAR. Cell 66:675, 1991
9. Longo L, Pandolfi PP, Biondi A, Rambaldi A, Mencarelli A, Lo Coco F, Diverio D, Pegoraro L, Avanzi G, Tabilio A, Donti E, Grignani F, Pelicci PG: Rearrangements and aberrant expression of the retinoic acid receptor a gene in acute promyelocytic leukemia. J Exp Med 172:1571, 1990
10. Miller WH Jr, Warrell RP Jr, Frankel SR, Jakubowski A, Gabrilove JL, Muindi J, Dmitrovsky E: Novel retinoic acid receptor a transcript in acute promyelocytic leukemia responsive to all-transretinoic acid. J Natl Cancer Inst 82:1932, 1990
11. Bernard J, Weil M, Boiron M, Jacquillat C, Flandrin G, Gemon MF: Acute promyelocytic leukemia. Results of treatment with daunorubicin. Blood 41:489, 1973
12. Marty M, Ganem G, Fischer J, Flandrin G, Berger R, Schaison G, Degos L, Boiron M: Leucémie aiguë promyélocitaire: Étude retrospective de 119 malade traités par daunorubicine. Nouv Rev Fr Hématol 26:371, 1984
13. Petti MC, Avvisati G, Amadori S, Baccarani M, Guarini AR, Papa G, Rosti GA, Tura S, Mandelli F: Acute promyelocytic leukaemia: Clinical aspects and results of treatment in 62 patients. Haematologica 72:151, 1987
14. Sanz MA, Jarque I, Martin G, Lorenzo I, Martinez J, Rafecas J, Pastor E, Sayas MJ, Sanz G, Gomis, F: Acute promyelocytic leukemia. Therapy results and prognostic factors. Cancer 61:7, 1988
15. Mandelli F, Petti MC, Avvisati G, Amadori S, Broccia G, Carella AM, Carotenuto M,Di Raimondo F, Fioritoni G, Lazzarino M, Leone G, Martelli M, Mirto S, Peta A, Petti N, Resegotti L, Specchia G, Vegna ML: GIMEMA experience in the treatment of adult acute myelogenous leukemia, in Gale RP (ed): Acute Myelogenous Leukemia. Progress and Controversies. New York, NY, Wiley-Liss, Inc. 1990, p 273
16. Avvisati G, Mandelli F, Petti MC, Vegna ML, Spadea A, Liso V, Specchia G, Bernasconi C, Alessandrino EP, Piatti C, Carella AM: Idarubicin (4-demethoxidaunorubicin) as single agent for remission induction of previously untreated acute promyelocytic leukaemia. A pilot study of the Italian cooperative group GIMEMA. Eur J Haematol 44:257, 1990
17. Huang ME, Ye YC, Chen SR, Chai JR, Lu HX, Zoha L, Gu LJ, Wang ZI: All-trans retinoic acid with or without low dose cytosine arabinoside in acute promyelocytic leukemia. Chin Med J 100:949, 1987
18. Huang ME, Ye YC, Chen SR, Chai JR, Lu HX, Zoha L, Gu LJ, Wang ZI: Use of all-trans retinoic acid in the treatment of acute promyelocytic leukemia. Blood 72:567, 1988
19. Castaigne S, Chomienne C, Daniel MT, Ballerini P, Berger R, Fenaux P, Degos L: All-trans retinoic acid as a differentiation therapy for acute promyelocytic leukemia: I. Clinical results. Blood 76:1704, 1990
20. Warrell RP, Frankel SR, Miller WH Jr, Scheinberg DA, Itri LM, Hittelman WN, Vyas R, Andreef M, Tafuri A, Jakubowski A, Gabrilove J, Gordon MS, Dimitrowski E: Differentiation therapy of acute promyelocytic leukemia with tretinoin (all-trans-retinoic acid). N Engl J Med 324:1385, 1991
21. Chen Z-X, Xue Y-Q, Zhang R, Tao RF, Xia XM, Li C, Wang W, Zu WY, Yao XZ, Ling BJ: A clinical and experimental study on all-trans retinoic acid-treated acute promyelocytic leukemia patients. Blood 78:1413, 1991
22. Avvisati G, Petti MC, Liso V, Lazzarino M, Leone G, Resegotti L, Fioritoni G, Mandelli F: All-trans retinoic acid (ATRA) in the treatment of acute promyelocytic leukemia (APL): Experience of the Italian cooperative group GIMEMA. Blood 82:250a, 1993 (suppl 1, abstr)
23. Ohno R, Yoshida H, Fukutani H, Naoe T, Ohshima T, Kyo T, Endoh N, Fujimoto T, Kobayashi T, Hiraoka A, Mizoguchi H, Kodera Y. Suzuki H, Hirano M, Akiyama H, Aoki N, Shindo H, Yokomaku S, the Leukaemia Study Group of the Ministry of Health and Welfare: Multi-institutional study of all-trans-retinoic acid as a differentiation therapy of refractory acute promyelocytic leukemia. Leukemia 7:1722, 1993
24. Frankel SR, Eardley A, Heller G, Berman E, Miller WH, Dmitrovsky E, Warrell RP: All-trans retinoic acid for acute promyelocytic leukemia. Results of the New York study. Ann Intern Med 120:1722, 1995
25. Lo Coco F, Avvisati G, Diverio D, Petti MC, Alcalay M, Pandolfi PP, Zangrilli D, Biondi A, Rambaldi A, Moleti MR, Mandelli F, Pelicci PG: Molecular evaluation of all-trans retinoic acid therapy in patients with acute promyelocytic leukemia. Blood 77:1657, 1991
26. Fenaux P, Castaigne S, Dombret H, Archimbaud E, Duarte M, Morel P, Lamy T, Tilly H, Guerci A, Maloisel F, Bordessoule D, Sadoun A, Tiberghien P, Fegueux N, Daniel MT, Chomienne C, Degos L: All-trans retinoic acid followed by intensive chemotherapy gives a high complete remission and may prolong remissions in newly diagnosed acute promyelocytic leukemia: A pilot study of 26 patients. Blood 80:2176, 1992
27. Fenaux P, Le Deley MC, Castaigne S, Archimbaud E, Chomienne C, Link H, Guerci A, Duarte M, Daniel MT, Bowen D, Huebner G, Bauters F, Fegueux N, Fey M, Sanz B, Lowenberg B, Maloisel F, Auzanneau G, Sadoun A, Gardin C, Bastion Y, Ganser A, Jacky E. Dombret H, Chastang C, Degos L, the European APL 91 Group: Effect of all-trans retinoic acid in newly diagnosed acute promyelocytic leukemia. Results of a multicenter randomized trial. Blood 82:3241, 1993
28. Lo Coco F, Diverio D, Pandolfi PP, Biondi A, Rossi V, Avvisati G, Rambaldi A, Arcese W, Petti MC, Meloni G, Mandelli F, Grignani F, Masera G, Barbui T, Pelicci PG: Molecular evaluation of residual disease as a predictor of relapse in acute promyelocytic leukaemia. Lancet 340:1437, 1992
29. Diverio D, Pandolfi PP, Biondi A, Avvisati G, Petti MC, Mandelli F, Pelicci PG, Lo Coco F: Absence of RT-PCR detectable residual disease in patients with acute promyelocytic leukemia in long term remission. Blood 82:3556, 1993
30. th Congress of the International Society of Haematology. Br J Haematol 221, 1992 (abstr 842)
31. Bennett JM, Catovsky D, Daniel MT, Flandrin G, Galton DA, Gralnick HR, Sultan C: Proposed revised criteria for the classification of acute myeloid leukemia. A report of the French-American-British cooperative group. Ann Intern Med 103:620, 1985
32. Frankel SR, Eardley A, Lauwers G. Weiss M, Warrell RP Jr, The "retinoic acid syndrome" in acute promyelocytic leukemia. Ann Intern Med 117:292, 1992
33. Chomczynsky P, Sacchi N: Single-step method of RNA isolation by acid guanidium thiocyanate-phenol-chloroform extraction. Ann Biochem 162:156, 1987
34. Kaplan E, Meier P: Nonparametric estimation from incomplete observations. J Am Stat Assoc 53:457, 1958
35. Kanamaru A, Takemoto Y, Tanimoto M, Murakami H, Asou N, Kobayashi T, Kuriyama K, Ohmoto E, Sakamaki H, Tsubaki K, Hiraoka A, Yamada O, Oh H, Saito K, Matsuda S, Minato K, Ueda T, Ohno R and the Japan Adult Leukaemia Study Group: All-trans retinoic acid for the treatment of newly diagnosed acute promyelocytic leukemia. Blood 85:1202, 1995
36. Head D, Kopecky KJ, Weick J, Files JC, Ryan D, Foucar K, Montiel M, Bickers J, Fishleder A, Miller M, Spier C, Hanson C, Bitter M, Braziel R, Mills G, Welborn J, Williams W, Hewlett J, Willman C, Appelbaum FR: Effect of aggressive daynomycin therapy on survival in acute promyelocytic leukemia. Blood 86:1717, 1995
37. Diverio D, Pandolfi PP, Rossi V, Biondi A, Pelicci PG, Lo Coco F: Monitoring of treatment outcome in acute promyelocytic leukemia by RT-PCR. Leukemia 8:1105, 1994
38. Dubois C, Schlageter MH, De Gentile A, Guidez F, Balitrand N, Toubert ME, Krawice I, Fenaux P, Castaigne S, Najean Y, Degos L, Chomienne C: Hematopoietic growth factor expression and ATRA sensitivity in acute promyelocytic blast cells. Blood 83:3264, 1994
39. Dubois C, Schlageter MH, De Gentile A, Guidez F, Balitrand N, Toubert ME, Krawice I, Fenaux P, Castaigne S, Najean Y, Degos L, Chomienne C: Modulation of IL-6 and IL-1b and G-CSF secretion by all trans retinoic acid in acute promyelocytic leukemia. Leukemia 8:1750, 1994
40. Di Noto R, Schiavone EM, Ferrara F, Manzo C, Lo Pardo C, Del Vecchio L: Expression and ATRA-driven modulation of adhesion molecules in acute promyelocytic leukemia. Leukemia 8:1900, 1994
41. Pinto A, Aldinucci D, Zagonel V, Di Noto R, Gattei V, Juzbasic S, Improta S, Perin V, Del Vecchio L, Canale V, Grignani F, Pelicci PG: In vitro ad in vivo regulation of adhesion molecules in acute promyelocytic leukemia (APL) cells by the PML-RARα gene product and all-trans-retinoic acid (ATRA). Proc Am Soc Clin Oncol 14:389, 1995 (abstr no. 1215)
42. Olson JA: The biological role of vitamin A in maintaining epithelial tissues. Israel J Med Sci 8:1170, 1974
43. Rodeghiero F, Avvisati G, Castaman G, Barbui T, Mandelli F: Early deaths and antihemorrhagic treatments in acute promyelocytic leukemia. A GIMEMA retrospective study in 268 consecutive patients. Blood 11:2112, 1990
44. Dombret H, Scrobohaci ML, Ghorra P, Zini JM, Daniel MT, Castaigne S, Degos L: Coagulation disorders associated with acute promyelocytic leukemia: Corrective effect of all-trans retinoic acid treatment. Leukemia 7:2, 1993
45. Avvisati G, Dragoni F, Chistolini A, Mazzucconi MG, Pallotta A, Latagliata R, Petti MC, Mandelli F: Rapid amelioration of the coagulopathy in acute promyelocytic leukemia (APL) treated with a combination of all-trans-retinoic acid (ATRA) plus idarubicin (AIDA protocol). Thromb Haemost 73:1432, 1995 (abstr no. 2034)
46. Falanga A, Iacoviello L, Evangelista V, Belotti D, Consonni R, D'Orazio A, Robba L, Donati MB, Barbui T: Loss of blast procoagulant activity and improvement of hemostatic variables in patients with acute promyelocytic leukemia administered all-trans-retinoic acid. Blood 86:1072, 1995
47. Fenaux P, Wattel E, Archimbaud E, Sanz M, Hecquet B, Guerci A, Link H, Fegueux N, Fey M, Castaigne S, Degos L: Prolonged follow up confirms that all-trans retinoic acid (ATRA) followed by chemotherapy reduces the risk of relapse in newly diagnosed acute promyelocytic leukemia (APL). Blood 84:666, 1994
48. Fenaux P, Chastang C, Chomienne C, Degos L: Tretinoin with chemotherapy in newly diagnosed acute promyelocytic leukaemia. Lancet 343:1033, 1994
49. Degos L, Dombret H, Chomienne C, Daniel MT, Micléa JM, Chastang C, Castaigne S, Fenaux P: All-trans retinoic acid as a differentiating agent in the treatment of acute promyelocytic leukemia. Blood 85:2643, 1995
50. Lo Coco F, Diverio D, Avvisati G, Luciano A, Biondi A, Mandelli F for the GIMEMA and AIEOP Cooperative groups: High frequency of early molecular remission in acute promyelocytic leukemia by combined all-trans retinoic acid and idarubcin (Italian GIMEMA-AIEOP "AIDA" trial). Blood 86:265a, 1995 (suppl 1, abstr)